Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 458
Immune Disorders Drugs 196
Cardiovascular Drugs 161
Drug Discovery 148
Infectious Diseases Drugs 132
Biopharmaceuticals 127
Endocrine and Metabolic Disorders Drugs 113
Clinical Trials 107
Central Nervous System Drugs 106
Musculoskeletal Disorders Drugs 98
Pharmaceuticals 96
Leukemia Drugs 82
Hematological Drugs 80
Liver and Kidney Disorders Drugs 76
Lymphoma Drugs 62
Dermatological Drugs 59
Diabetes Drugs 57
Skin Cancer Drugs 48
Brain Cancer Drugs 46
Respiratory Drugs 45
Mental Disorders Drugs 43
Lung Cancer Drugs 39
Gastrointestinal Drugs 38
Drug Delivery 36
Pharmaceutical Intermediates 34
Immunosuppressive Drugs 33
Pharmaceutical Manufacturing 31
Infusions and Injectables 30
Liver Cancer Drugs 29
Analgesics 27
Antibiotics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 21
Pancreatic Cancer Drugs 19
Prostate Cancer Drugs 18
HIV/AIDS Drugs 18
Urological Disorders Drugs 18
Colon Cancer Drugs 17
Schizophrenia Drugs 17
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Ovarian Cancer Drugs 15
Thyroid Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Psoriasis Drugs 12
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Vaccines 8
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



280 reviews

2,424 Results (Page 77 of 122)
- Relevance
  Sort by

Stomach Cancer Treatment - Global Strategic Business Report

 Report
August 2025
371 Pages
Global

From

€5199EUR$5,850USD£4,501GBP

Sialorrhea Treatment Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Medical Therapy and End User

 Report
December 2023
150 Pages
Global

From

€3955EUR$4,450USD£3,424GBP

Rare Diseases Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Specialty Pharmacy, Hospital Pharmacy, and Online Pharmacy), By Route of Administration, By Therapeutic Area, By Regional Outlook and Forecast, 2022 - 2028

 Report
August 2022
308 Pages
Global

From

€3200EUR$3,600USD£2,770GBP

Cancer Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Large B-Cell Lymphoma, Multiple Myeloma), By Vector Type (Lentivirus, RetroVirus & Gamma RetroVirus, AAV), By Route Of Administration, By Region, And Segment Forecasts, 2025 - 2030

 Report
June 2025
120 Pages
Global

From

€5288EUR$5,950USD£4,578GBP

PD-1 and PD-L1 Inhibitors Market 2024-2028

 Report
October 2024
136 Pages
Global

From

€2222EUR$2,500USD£1,924GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Immunotherapy Drugs - Global Strategic Business Report

 Report
August 2025
193 Pages
Global

From

€5199EUR$5,850USD£4,501GBP

Combination Antibody Therapy - Global Strategic Business Report

 Report
August 2025
196 Pages
Global

From

€5199EUR$5,850USD£4,501GBP

Gynecological Cancer Drugs - Global Strategic Business Report

 Report
August 2025
193 Pages
Global

From

€5199EUR$5,850USD£4,501GBP

Immuno-Oncology - Global Strategic Business Report

 Report
August 2025
224 Pages
Global

From

€5199EUR$5,850USD£4,501GBP

Immune Checkpoint Inhibitors - Global Strategic Business Report

 Report
August 2025
194 Pages
Global

From

€5199EUR$5,850USD£4,501GBP

Malignant Mesothelioma - Global Strategic Business Report

 Report
August 2025
193 Pages
Global

From

€5199EUR$5,850USD£4,501GBP

Chemotherapy Treatment - Global Strategic Business Report

 Report
August 2025
188 Pages
Global

From

€5199EUR$5,850USD£4,501GBP

Myeloproliferative Neoplasms Treatment - Global Strategic Business Report

 Report
August 2025
368 Pages
Global

From

€5199EUR$5,850USD£4,501GBP

Neuroendocrine Tumor Treatment - Global Strategic Business Report

 Report
August 2025
383 Pages
Global

From

€5199EUR$5,850USD£4,501GBP

Adenoid Cystic Carcinoma - Global Strategic Business Report

 Report
August 2025
386 Pages
Global

From

€5199EUR$5,850USD£4,501GBP

Angiosarcoma Treatment - Global Strategic Business Report

 Report
August 2025
390 Pages
Global

From

€5199EUR$5,850USD£4,501GBP

Hedgehog Pathway Inhibitors - Global Strategic Business Report

 Report
August 2025
102 Pages
Global

From

€5199EUR$5,850USD£4,501GBP

Ewing Sarcoma - Global Strategic Business Report

 Report
August 2025
377 Pages
Global

From

€5199EUR$5,850USD£4,501GBP

$Checkpoint Inhibitor Refractory Cancer - Global Strategic Business Report - Product Thumbnail Image$

Checkpoint Inhibitor Refractory Cancer - Global Strategic Business Report

 Report
August 2025
287 Pages
Global

From

€5199EUR$5,850USD£4,501GBP

CAR T-cell Therapy Market Size, Share & Trends Analysis Report by Product (Abecma, Breyanzi, Carvykti, Kymriah), Disease Indication (Lymphoma, Leukemia, Multiple Myeloma), End-use, Region and Segment Forecasts, 2025-2030

 Report
May 2025
90 Pages
Global

From

€5288EUR$5,950USD£4,578GBP

2,424 Results (Page 77 of 122)
- 1
- 75
- 76
- 77
- 78
- 79

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.